Early relapse and refractory disease remain risk factors in the anthracycline and autologous transplant era for patients with relapsed/refractory classical Hodgkin lymphoma: A single centre intention-to-treat analysis

British Journal of Haematology

Volumn 157, Issue 2, 2012, Pages 201-204

  Greaves, Paul ^a   Wilson, Andrew ^a   Matthews, Janet ^a   Brown, Daniel L P ^b   Auer, Rebecca ^a   Montoto, Silvia ^a   Lister, T Andrew ^a   Gribben, John G ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Chemosensitivity; Hodgkins lymphoma; Transplant

Indexed keywords

BLEOMYCIN; CARMUSTINE; CHLORAMBUCIL; CHLORMETHINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; GEMCITABINE; MELPHALAN; METHYLPREDNISOLONE; PREDNISOLONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

ADULT; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER RELAPSE; CLASSICAL HODGKIN LYMPHOMA; FEMALE; HIGH RISK POPULATION; HUMAN; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RISK FACTOR; SALVAGE THERAPY; TREATMENT FAILURE; TREATMENT RESPONSE;

ADOLESCENT; ADULT; ANTHRACYCLINES; DISEASE-FREE SURVIVAL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMANS; MALE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; SALVAGE THERAPY; SURVIVAL RATE; TIME FACTORS; TRANSPLANTATION, AUTOLOGOUS;

EID: 84859213859     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2011.08993.x     Document Type: Article

References (14)

1. Chopra, R., McMillan, A.K., Linch, D.C., Yuklea, S., Taghipour, G., Pearce, R., Patterson, K.G. & Goldstone, A.H. (1993) The place of high-dose BEAM therapy and autologous bone marrow transplantation in poor-risk Hodgkin's disease. A single-center eight-year study of 155 patients. Blood, 81, 1137-1145.
2. Ferme, C., Mounier, N., Divine, M., Brice, P., Stamatoullas, A., Reman, O., Voillat, L., Jaubert, J., Lederlin, P., Colin, P., Berger, F. & Salles, G. (2002) Intensive salvage therapy with high-dose chemotherapy for patients with advanced Hodgkin's disease in relapse or failure after initial chemotherapy: results of the Groupe d'Etudes des Lymphomes de l'Adulte H89 Trial. Journal of Clinical Oncology, 20, 467-475.
3. Horning, S.J., Chao, N.J., Negrin, R.S., Hoppe, R.T., Long, G.D., Hu, W.W., Wong, R.M., Brown, B.W. & Blume, K.G. (1997) High-dose therapy and autologous hematopoietic progenitor cell transplantation for recurrent or refractory Hodgkin's disease: analysis of the Stanford University results and prognostic indices. Blood, 89, 801-813.
4. Linch, D.C., Winfield, D., Goldstone, A.H., Moir, D., Hancock, B., McMillan, A., Chopra, R., Milligan, D. & Hudson, G.V. (1993) Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial. Lancet, 341, 1051-1054.
5. Majhail, N.S., Weisdorf, D.J., Defor, T.E., Miller, J.S., McGlave, P.B., Slungaard, A., Arora, M., Ramsay, N.K., Orchard, P.J., MacMillan, M.L. & Burns, L.J. (2006) Long-term results of autologous stem cell transplantation for primary refractory or relapsed Hodgkin's lymphoma. Biology of Blood and Marrow Transplantation, 12, 1065-1072.
6. McElwain, T.J., Toy, J., Smith, E., Peckham, M.J. & Austin, D.E. (1977) A combination of chlorambucil, vinblastine, procarbazine and prednisolone for treatment of Hodgkin's disease. British Journal of Cancer, 36, 276-280.
7. Moskowitz, A.J., Yahalom, J., Kewalramani, T., Maragulia, J.C., Vanak, J.M., Zelenetz, A.D. & Moskowitz, C.H. (2010) Pretransplantation functional imaging predicts outcome following autologous stem cell transplantation for relapsed and refractory Hodgkin lymphoma. Blood, 116, 4934-4937.
8. Nademanee, A., O'Donnell, M.R., Snyder, D.S., Schmidt, G.M., Parker, P.M., Stein, A.S., Smith, E.P., Molina, A., Stepan, D.E., Somlo, G., Margolin, K.A., Sniecinski, I., Dagis, A.C., Niland, J., Pezner, R. & Forman, S.J. (1995) High-dose chemotherapy with or without total body irradiation followed by autologous bone marrow and/or peripheral blood stem cell transplantation for patients with relapsed and refractory Hodgkin's disease: results in 85 patients with analysis of prognostic factors. Blood, 85, 1381-1390.
9. Santoro, A., Magagnoli, M., Spina, M., Pinotti, G., Siracusano, L., Michieli, M., Nozza, A., Sarina, B., Morenghi, E., Castagna, L., Tirelli, U. & Balzarotti, M. (2007) Ifosfamide, gemcitabine, and vinorelbine: a new induction regimen for refractory and relapsed Hodgkin's lymphoma. Haematologica, 92, 35-41.
10. Schmitz, N., Pfistner, B., Sextro, M., Sieber, M., Carella, A.M., Haenel, M., Boissevain, F., Zschaber, R., Muller, P., Kirchner, H., Lohri, A., Decker, S., Koch, B., Hasenclever, D., Goldstone, A.H. & Diehl, V. (2002) Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial. Lancet, 359, 2065-2071.
11. Smith, S.D., Moskowitz, C.H., Dean, R., Pohlman, B., Sobecks, R., Copelan, E., Andresen, S., Bolwell, B., Maragulia, J.C., Vanak, J.M., Sweetenham, J. & Moskowitz, A.J. (2011) Autologous stem cell transplant for early relapsed/refractory Hodgkin lymphoma: results from two transplant centres. British Journal of Haematology, 153, 358-363.
12. Sureda, A., Arranz, R., Iriondo, A., Carreras, E., Lahuerta, J.J., Garcia-Conde, J., Jarque, I., Caballero, M.D., Ferra, C., Lopez, A., Garcia-Larana, J., Cabrera, R., Carrera, D., Ruiz-Romero, M.D., Leon, A., Rifon, J., Diaz-Mediavilla, J., Mataix, R., Morey, M., Moraleda, J.M., Altes, A., Lopez-Guillermo, A., de la Serna, J., Fernandez-Ranada, J.M., Sierra, J. & Conde, E. (2001) Autologous stem-cell transplantation for Hodgkin's disease: results and prognostic factors in 494 patients from the Grupo Espanol de Linfomas/Transplante Autologo de Medula Osea Spanish Cooperative Group. Journal of Clinical Oncology, 19, 1395-1404.
13. Sweetenham, J.W., Carella, A.M., Taghipour, G., Cunningham, D., Marcus, R., Della Volpe, A., Linch, D.C., Schmitz, N. & Goldstone, A.H. (1999) High-dose therapy and autologous stem-cell transplantation for adult patients with Hodgkin's disease who do not enter remission after induction chemotherapy: results in 175 patients reported to the European Group for Blood and Marrow Transplantation. Lymphoma Working Party. Journal of Clinical Oncology, 17, 3101-3109.
14. Younes, A., Bartlett, N.L., Leonard, J.P., Kennedy, D.A., Lynch, C.M., Sievers, E.L. & Forero-Torres, A. (2010) Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas. New England Journal of Medicine, 363, 1812-1821.